Intermittent Hypoxia Intervention in MS Patients
NCT04635033 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12
Last updated 2020-11-18
Summary
This observational cohort study investigates the safety and feasibility of an intermittent hypoxia intervention in multiple sclerosis.
Conditions
Sponsors & Collaborators
-
Universitätsklinikum Hamburg-Eppendorf
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-09-19
- Primary Completion
- 2019-10-10
- Completion
- 2019-10-10
Countries
- Germany
Study Locations
More Related Trials
-
An Observational Biomarker Study in Multiple Sclerosis (MS) Patients
NCT05663853 ·Status: COMPLETED
-
Validation of Multimodal Evoked Potentials (mmEP) for Predicting Disease Progression in Multiple Sclerosis
NCT03632473 ·Status: COMPLETED
-
Ischemic Preconditioning, Exercise Tolerance and Multiple Sclerosis
NCT03153553 ·Status: COMPLETED ·Phase: NA
-
Study Evaluating Mitoxantrone in Multiple Sclerosis
NCT00146159 ·Status: TERMINATED ·Phase: PHASE3
-
Acute Intermittent Hypoxia in Persons With Multiple Sclerosis
NCT04280484 ·Status: COMPLETED ·Phase: NA
-
Three Months Treatment With SB683699 In Patients With Relapsing Multiple Sclerosis
NCT00097331 ·Status: COMPLETED ·Phase: PHASE2
-
Immunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
NCT00342134 ·Status: COMPLETED ·Phase: PHASE2
-
Neural Stem Cell Transplantation in Multiple Sclerosis Patients
NCT03269071 ·Status: COMPLETED ·Phase: PHASE1
-
Baseline Cortical Haemodynamics in MS
NCT02481882 ·Status: UNKNOWN ·Phase: NA
-
Consolidation & Interference in Multiple Sclerosis
NCT02081508 ·Status: COMPLETED ·Phase: NA
-
Transient and Immediate Motor Effects of Exercise in Progressive Multiple Sclerosis
NCT05562414 ·Status: UNKNOWN ·Phase: NA
-
Development and Evaluation of a Web-based Programme on Relapse Management for People With Multiple Sclerosis
NCT04233970 ·Status: COMPLETED ·Phase: NA
-
Treating New Learning and Memory Deficits in Progressive Multiple Sclerosis (MS)
NCT02301247 ·Status: COMPLETED ·Phase: NA
-
Multiple Sclerosis Treatment With Autologous Hematopoietic Stem Cell Transplantation in the Netherlands
NCT06567197 ·Status: RECRUITING
-
Tolerability and Safety and Health Outcomes in Relapsing Multiple Sclerosis (MS) Patients
NCT01127750 ·Status: COMPLETED ·Phase: PHASE3
-
Hematopoietic Stem Cell Transplantation for Treatment of Multiple Sclerosis in Sweden
NCT05029206 ·Status: COMPLETED
-
Feasibility and Reliability of Multimodal Evoked Potentials
NCT03686826 ·Status: COMPLETED
-
Intrathecal Therapy With Monoclonal Antibodies in Progressive Multiple Sclerosis
NCT01719159 ·Status: COMPLETED ·Phase: PHASE2
-
Development of a Novel Functional Eye-Tracking Software Application for Multiple Sclerosis
NCT05061953 ·Status: RECRUITING
-
Immunoadsorption Versus High-dose Intravenous Corticosteroids in Relapsing Multiple Sclerosis
NCT04450030 ·Status: UNKNOWN
-
ATX-MS-1467 in Multiple Sclerosis
NCT01973491 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Autologous Hematopoietic Stem Cell Transplantation on the Lower Urinary Tract Function Related to QoL in MS Patients
NCT06218927 ·Status: RECRUITING
-
"HB-adMSCs for the Treatment of Patients With Multiple Sclerosis"
NCT06800404 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Computerized Exercise Training for Cognitive Remediation in Adults With Multiple Sclerosis Treated With Gilenya
NCT02141022 ·Status: COMPLETED ·Phase: NA
-
A Study of Multiple Sclerosis Routine Clinical Practice: Impact on Adherence and Clinical Outcomes of Ofatumumab Treated Patients
NCT06897657 ·Status: COMPLETED